Drugs / Delapril
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT00157586 | Feb 2002 → Jun 2008 | type 2 diabetes mellitus | Mario Negri Institute for Pharmacological Research | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00627952 Comparator | Nov 2007 → Dec 2008 | hypertensive disorder | University of Erlangen-Nürnberg Medical School | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Delapril | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00157586 ↗ |
| Known as | Adecut | ChEMBL registry synonym — accepted as the source's own label CHEMBL589583 ↗ |
| Known as | Delapril hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL589583 ↗ |
| Known as | DELAPRIL HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL589583 ↗ |
| Known as | REV 6000A | ChEMBL registry synonym — accepted as the source's own label CHEMBL589583 ↗ |
| Action | Inhibit | “the ACE inhibitor delapril” NCT00157586 ↗ |
| Modality | Small molecule | — CHEMBL589583 ↗ |
| Target | ACE | “the ACE inhibitor delapril” NCT00157586 ↗ |